Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 5/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7047495 | 0.93 | ABCC9 (0.55) | ABCC9 | |
| SCHEMBL7475675 | 0.91 | ABCC9 (0.59) | ABCC9 | |
| SCHEMBL7475685 | 0.91 | ABCC9 (0.59) | ABCC9 | |
| SCHEMBL7477937 | 0.91 | ABCC9 (0.59) | ABCC9 | |
| SCHEMBL7481173 | 0.89 | ABCC9 (0.66) | ABCC9 | |
| SCHEMBL7481178 | 0.89 | ABCC9 (0.66) | ABCC9 | |
| SCHEMBL7482702 | 0.89 | ABCC9 (0.66) | ABCC9 | |
| Carabersat SCHEMBL3301553 | 0.88 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL3308650 | 0.88 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL3300409 | 0.88 | ABCC9 (0.62) | ABCC9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1091950-B1 | SUBSTITUTED BENZOPYRAN DERIVATIVES AND THEIR USE AS ANTICONVULSANTS | SMITHKLINE BEECHAM PLC (GB) | 2003-04-09 | — | — | EP | claimed |
| US-6395909-B1 | DRUGS FOR ANTICONVULSANTS | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-05-28 | — | — | US | claimed |
| EP-1091950-A1 | SUBSTITUTED BENZOPYRAN DERIVATIVES AND THEIR USE AS ANTICONVULSANTS | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | claimed |
| WO-2000000484-A1 | SUBSTITUTED BENZOPYRAN DERIVATIVES AND THEIR USE AS ANTICONVULSANTS | SMITHKLINE BEECHAM PLC (GB) | 2000-01-06 | — | — | WO | claimed |
| US-20040024220-A1 | Lipids | CELLTECH R & D LIMITED | 2004-02-05 | — | — | US | disclosed |
| EP-1091950-B1 | SUBSTITUTED BENZOPYRAN DERIVATIVES AND THEIR USE AS ANTICONVULSANTS | SMITHKLINE BEECHAM PLC (GB) | 2003-04-09 | — | — | EP | disclosed |
| US-6395909-B1 | DRUGS FOR ANTICONVULSANTS | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-05-28 | — | — | US | disclosed |
| EP-1091950-A1 | SUBSTITUTED BENZOPYRAN DERIVATIVES AND THEIR USE AS ANTICONVULSANTS | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000000484-A1 | SUBSTITUTED BENZOPYRAN DERIVATIVES AND THEIR USE AS ANTICONVULSANTS | SMITHKLINE BEECHAM PLC (GB) | 2000-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040024220-A1 | Lipids | PHOSPHO1, FABP7, MBOAT7 | ABCC9 3265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.